HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunogenicity of a Haemophilus influenzae type b-tetanus conjugate vaccine when administered separately or in combined vaccines for primary immunization in two consecutive national schedules in Turkey.

AbstractBACKGROUND:
In Turkey, the Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (Hib) was replaced by the combined diphtheria-tetanus-acellular pertussis and inactivated polio vaccine (DTaP-IPV/Hib) in 2008. This shift to the new schedule created different cohorts of vaccinated children as a consequence of the different schedules used. We evaluated the immunogenicity of the Hib vaccine in infants vaccinated with these different schedules.
METHODS:
Three groups of children were evaluated: group 1 comprised 145 infants vaccinated with diphtheria, tetanus, and whole cell pertussis (DTwP), oral polio vaccine (OPV), and Hib vaccines simultaneously at separate sites; group 2 comprised 204 infants vaccinated with the DTaP-IPV/Hib combined vaccine; group 3 comprised 100 infants vaccinated with a mixed schedule of DTwP, OPV, and Hib for the first one or two doses, followed by DTaP-IPV/Hib vaccine to complete the series.
RESULTS:
Anti-polyribosylribitol phosphate (anti-PRP) titers ≥0.15μg/ml were similar in groups 1, 2, and 3. However, in group 1, who received all the vaccines at separate sites, ≥ l.0μg/ml long-lasting antibody titers and anti-PRP geometric mean titers were higher (p=0.001).
CONCLUSION:
This study showed that even one dose administered in combination with other vaccines in a primary series decreased the level of anti-PRP.
AuthorsNurullah Yüksel, Ufuk Beyazova, Işil Fidan Balci, Fatma Nur Aksakal, Aysu Duyan Camurdan, Figen Sahin, Seyyal Rota
JournalInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (Int J Infect Dis) Vol. 16 Issue 5 Pg. e354-7 (May 2012) ISSN: 1878-3511 [Electronic] Canada
PMID22387144 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Antibodies, Bacterial
  • Diphtheria Toxoid
  • Haemophilus Vaccines
  • Pertussis Vaccine
  • Poliovirus Vaccine, Inactivated
  • Polysaccharides
  • Tetanus Toxoid
  • Vaccines, Acellular
  • Vaccines, Combined
  • polyribitol phosphate
Topics
  • Antibodies, Bacterial (blood)
  • Diphtheria Toxoid (administration & dosage)
  • Haemophilus Infections (prevention & control)
  • Haemophilus Vaccines (administration & dosage, immunology)
  • Haemophilus influenzae type b (immunology)
  • Humans
  • Infant
  • Mass Vaccination
  • Pertussis Vaccine (administration & dosage)
  • Poliovirus Vaccine, Inactivated (administration & dosage)
  • Polysaccharides (immunology)
  • Population Surveillance
  • Tetanus Toxoid (administration & dosage)
  • Turkey
  • Vaccines, Acellular (administration & dosage)
  • Vaccines, Combined (administration & dosage, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: